NASDAQ: GLSI - Greenwich LifeSciences, Inc.

Yield per half year: -34.58%
Sector: Healthcare

Share chart Greenwich LifeSciences, Inc.


About

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.


IPO date 2020-09-25
ISIN US3968791083
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://greenwichlifesciences.com
Цена ао 20.32
Change price per day: -3.12% (11.87)
Change price per week: -7.18% (12.39)
Change price per month: -21.07% (14.57)
Change price per 3 month: -18.73% (14.15)
Change price per half year: -34.58% (17.58)
Change price per year: +9.32% (10.52)
Change price per 3 year: -59.62% (28.48)
Change price per 5 year: 0% (11.5)
Change price per 10 year: 0% (11.5)
Change price per year to date: -15.81% (13.66)

Underestimation

Title Value Grade
P/S 0 0
P/BV 21.32 1
P/E 0 0
EV/EBITDA -14.57 0
Total: 1.63

Efficiency

Title Value Grade
ROA, % -127.12 0
ROE, % -132.71 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 174.24 10
Yield EPS, % 141.81 10
Total: 8

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.02306 13.79 1.54048
Vanguard Russell 2000 Growth ETF 0.01 17.39 0.60264
iShares Russell 2000 Growth ETF 0.00627 38.04 0.6026
ProShares UltraPro Russell2000 0.00192 89.82 1.47873
ProShares Hedge Replication ETF 0.0005 5.92 1.47892
Vanguard Russell 2000 ETF 0 14.37 1.48801
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Mr. Snehal S. Patel CEO, CFO & Director 1.09M 1964 (61 year)
Mr. Eric Rothe Founder & Independent Director 65.64k 1976 (49 years)
Dr. Frank Joseph Daugherty M.D. Chief Medical Officer & Director N/A 1951 (74 years)
Dr. Jaye L. Thompson Ph.D. Vice President Clinical & Regulatory Affairs N/A 1966 (59 years)
Dr. Christine T. Fischette Ph.D. VP of Business Development N/A 1951 (74 years)

Address: United States, Stafford. TX, Building 14 - open in Google maps, open in Yandex maps
Website: https://greenwichlifesciences.com